STOCK TITAN
  1. Home
  2. PDLI

PDL BioPharma (PDLI) Stock Price, News & Analysis

PDLI NASDAQ

Company Description

PDL BioPharma (NASDAQ: PDLI) is classified in the biological product (except diagnostic) manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for PDLI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
114.2M
Shares outstanding

Latest News

View All
+5.20%

PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat

-4.67%

PDL Announces Timeline for Voluntarily Delisting from Nasdaq

+1.77%

PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution

earnings
-3.13%

PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update

earnings
0.00%

PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020

earnings
-18.94%

PDL BioPharma Completes Spin-Off of LENSAR

PDL BioPharma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings. View all PDLI news →

SEC Filings

View All

No SEC filings available for PDLI.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PDLI Company Profile & Sector Positioning

PDL BioPharma (PDLI) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.